How to Help Your Patients Save Money on Rhofade: A Provider's Guide to Savings Programs

For dermatologists and other prescribers, the cost of Rhofade is a regular conversation in the clinic. With an average retail price near $861 per 30g tube and no generic available, patients on tight budgets or government insurance programs often face real access barriers. This guide equips providers with the key savings programs, formulary navigation strategies, and patient communication tools to make Rhofade more affordable for those who need it.

Understanding the Cost Landscape for Rhofade

To counsel patients effectively, providers should understand the major pricing tiers for Rhofade:

Wholesale Acquisition Cost (WAC): ~$340 per 15g tube (this is what pharmacies pay, not what patients see)

Retail (cash) price: ~$861 for 30g at full retail without any discount

With insurance + prior auth: Typically $50–$60 patient out-of-pocket after approval

With Mayne Pharma Copay Card + insurance: As low as $0 for eligible commercially insured patients

GoodRx coupon (uninsured or cash-pay): As low as $45 at participating pharmacies (prices vary by location)

Program 1: Mayne Pharma Copay Savings Card (RWET Program)

The Mayne Pharma Copay Savings Card is the most impactful savings tool for commercially insured patients. Key program details for 2026:

Patient savings: Copay reduced to as low as $0 per fill for eligible patients

Eligibility: Must have commercial insurance coverage for Rhofade. NOT available for Medicare, Medicaid, TRICARE, VA, DOD, or IHS beneficiaries.

Expiration: December 31, 2026 (valid prescriptions must be filled before this date)

How patients access it: Download from rhofade.com or call 347-442-7919

Provider recommendation: Consider making the Copay Savings Card part of your standard Rhofade prescription workflow. Print a QR code to the savings card page and include it in patient discharge materials for any Rhofade prescription. Your front desk staff can direct patients to obtain the card before their first fill.

Program 2: Prior Authorization — Getting It Right the First Time

The single most common reason commercially insured patients pay full retail for Rhofade is a missing or incomplete prior authorization. Most major payers cover Rhofade once PA criteria are met. A robust PA submission includes:

Diagnosis: ICD-10 L71.9 or appropriate subtype (confirmed rosacea with persistent facial erythema)

Clinical description: severity, duration, and functional impact of erythema

Treatment history: prior therapies tried, their outcomes, and reason Rhofade is specifically indicated

Drug interaction review attestation (required by some payers including Minnesota Medicaid)

For practices with high dermatology volume, consider a standardized PA letter template for Rhofade. PA reauthorizations (typically required every 12 months by major payers like UHC) should document clinical response with quantitative measures where possible.

Program 3: Handling PA Denials and Appeals

If a PA is denied, the appeal process is worth pursuing. The American Academy of Dermatology has documented that 64.6% of prescription appeals are ultimately approved when properly pursued. Effective appeals include:

A clinical letter documenting medical necessity in your own words (not just payer-form language)

Reference to published clinical evidence supporting Rhofade's efficacy for erythema reduction

Documentation that the denied step-therapy alternatives were inadequate or inappropriate for this specific patient

39,049+ patients found their medications in stock

39K+

Find Rhofade In Stock Today →

Program 4: Patient Assistance for Uninsured or Low-Income Patients

For patients without commercial insurance or who cannot afford Rhofade even with discounts, patient assistance programs (PAPs) may provide the medication at reduced or no cost. Resources to direct patients to include Mayne Pharma's patient assistance program (confirm details directly with company as criteria can change), NeedyMeds (needymeds.org), the Patient Advocate Foundation (patientadvocate.org), and RxAssist (rxassist.org). PAP applications typically require prescriber participation — plan for 2-4 weeks for processing and approval.

Program 5: Medicare Patients — Specific Guidance

Medicare patients cannot use the Mayne Pharma Copay Savings Card. For Medicare Part D patients where Rhofade is covered on their plan, encourage them to ask their plan about the copay tier and whether mail-order provides a lower cost. For Medicare patients where Rhofade is not covered, GoodRx coupons are available to Medicare beneficiaries (they can use GoodRx instead of, but not alongside, Medicare). Alternatively, consider prescribing a covered generic alternative — generic azelaic acid 15% or generic metronidazole topical are both covered by most Medicare Part D plans.

Skip the calls, skip the stress.

Find Rhofade In Stock Today →

50K+

Medications
Found

99%

Success
Rate

6+

Hours saved
on average

How medfinder Supports Patient Access

Once cost is addressed, patients still need to physically find a pharmacy that has Rhofade in stock. Consider recommending medfinder for providers to your patients. Patients submit their medication, dosage, and location; medfinder contacts pharmacies near them to confirm which can fill the prescription. This reduces callback volume to your office and ensures patients aren't cycling through pharmacies on their own.

For a comprehensive clinical overview of Rhofade access barriers, see our Rhofade shortage briefing for providers.